Jian Zhang

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

Bi-Yun Wang, Jian Zhang, Jia-Lei Wang et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 179 citations · Full text

Medicine, Oncology, Pharmacology +15

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Jia Jin, Yu Gao, Jian Zhang et al. · BMC Cancer · 2018 · 117 citations · Full text

Medicine, Oncology, Breast Oncology +16

A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors

Junning Cao, Jian Zhang, Wei Peng et al. · Cancer Chemotherapy and Pharmacology · 2016 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +16

Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial

Herui Yao, Min Yan, Zhongsheng Tong et al. · Journal of Clinical Oncology · 2024 · 45 citations

Medicine, Oncology, Pharmacology +17

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

Jie Xie, Jun Cao, Jingfen Wang et al. · Breast Cancer Research and Treatment · 2017 · 34 citations

Medicine, Oncology, Pharmacotherapy +12